CTOs on the Move

Imaging Healthcare Specialists

www.imaginghealthcare.com

 
Imaging Healthcare Specialists is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

HealthLynked

HealthLynked (OTCQB: HLYK) provides a solution for both patient members and providers to improve healthcare by efficiently exchanging medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take control of their medical data. Members can enter their medications, allergies, past surgeries, and personal health records into one convenient online and secure location. Participating healthcare providers can connect with their current and future patients through the HealthLynked Network. Providers also get the benefit of using HealthLynked marketing tools to communicate with their active and inactive patients to improve patient retention, access accurate patient information, and provide efficient online scheduling.

AmRelieve

AmRelieve is a multinational eCommerce business operating in the health and wellbeing industry, with a focus on serving active seniors in pain free living. They offer a range of natural health products, including CBD balms and gummies, lumbar support b...

Kelly Productions Inc

Kelly Productions Inc is a Bel Air, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.

Chiltern

We are the leading, global mid-sized contract research organization. Our team of more than 4,200 employees working across 47 countries delivers collaborative clinical development services and solutions Designed Around You®.